“Sifuvirtide, a 36 amino acid negatively charged peptide,


“Sifuvirtide, a 36 amino acid negatively charged peptide, is a novel and promising HIV fusion inhibitor, presently in clinical trials. Because of the aromatic amino acid residues of the peptide, its GSK2879552 in vivo behavior in aqueous solution and the interaction with lipid-membrane model systems (large unilammelar vesicles) were studied by using mainly fluorescence spectroscopy techniques (both steady-state and time-resolved). No significant aggregation of the peptide

was observed with aqueous solution. Various biological and nonbiological lipid-membrane compositions were analyzed, and atomic force microscopy was used to visualize phase separation in several of those mixtures. Results showed no significant interaction of the peptide, neither with zwitterionic fluid lipid membranes (liquid-disordered phase), nor with cholesterol-rich membranes (liquid-ordered phase). However, significant partitioning was observed with the positively charged lipid models (K-p = (2.2 +/- 0.3) x 10(3)), serving as a positive control. Fluorescence quenching using Forster resonance

acrylamide and lipophilic probes was carried out to study the location of the peptide in the membrane models. In the gel-phase DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) membrane model, an adsorption of the peptide at the surface of these membranes was observed and confirmed by using Forster resonance energy-transfer experiments. These results indicate a targeting of the peptide Pexidartinib chemical structure to gel-phase domains relatively to liquid-disordered Angiogenesis inhibitor or liquid-ordered phase domains. This larger affinity and selectivity toward the more rigid areas of the membranes, where most of the receptors are found, or to viral membrane, may help explain the improved clinical efficiency of sifuvirtide, by providing a local increased

concentration of the peptide at the fusion site.”
“Analysis of ethanol and water in consumer products is important in a variety of processes and often is mandated by regulating agencies. A method for the simultaneous quantitation of ethanol and water that is simple, accurate, precise, rapid, and cost-effective is demonstrated. This approach requires no internal standard for the quantitation of both ethanol and water at any/all levels in commercial products. Ionic liquid based gas chromatography (GC) capillary columns are used to obtain a fast analysis with high selectivity and resolution of water and ethanol. Typical run times are just over 3 min. Examination of the response range of water and ethanol with GC, thermal conductivity detection (TCD), and barrier ionization detection (BID) is performed. Quantitation of both ethanol and water in consumer products is accomplished with both TCD and BID GC detectors using a nonlinear calibration. Validation of method accuracy is accomplished by using standard reference materials.”
“Prostate cancer affects 3 in 10 men over the age of 50 years, and, unfortunately, the clinical course of the disease is poorly predicted.

Comments are closed.